Evolocumab in Patients without a Previous Myocardial Infarction or Stroke

E Erin A. Bohula (Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) N Nicholas A. Marston (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) A Ajay K. Bhatia (Amgen, Thousand Oaks, CA) G Gaetano M. De Ferrari (Cardiology Division, Department of Medical Sciences, University of Turin and Azienda Ospedaliero–Universitaria Città della Salute e della Scienza, Turin, Italy) L Lawrence A. Leiter (Division of Endocrinology and Metabolism, St. Michael’s Hospital, University of Toronto, Toronto) J Jose C. Nicolau (Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo) J Jeong-Gun Park (Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) J Julia F. Kuder (Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) S Sabina A. Murphy (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) E Emileigh Walsh (Amgen, Thousand Oaks, CA) H Huei Wang (Amgen, Thousand Oaks, CA) V Vladimír Blaha A Andrzej Budaj (Department of Cardiology, Center of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland) J Jan H. Cornel (Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Radboudumc, Nijmegen, the Netherlands) A Assen Goudev (Division of Cardiology, University Hospital Tsaritsa Yoanna, Sofia, Bulgaria) R Robert Gabor Kiss (Department of Cardiology, Central Hospital of Northern Pest-Military Hospital, Budapest, Hungary) A Alberto J. Lorenzatti (DAMIC (Docencia Asistencia Médica e Investigación Clínica) Medical Institute and Rusculleda Foundation for Research, Cordoba, Argentina) A Alexander Parkhomenko (National Scientific Center “M.D. Strazhesko Institute of Cardiology,” Kyiv, Ukraine) M Marcoli Cyrille (Amgen, Thousand Oaks, CA) G Gabriel Paiva da Silva Lima (Amgen, Thousand Oaks, CA) E E. Magnus Ohman (Amgen, Thousand Oaks, CA) R Robert P. Giugliano M Marc S. Sabatine (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston)

Article Details

Volume / Issue Vol. 394, Issue 2
Published January 08, 2026
Pages 117-127
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (23)

E

Erin A. Bohula

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

N

Nicholas A. Marston

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

A

Ajay K. Bhatia

Amgen, Thousand Oaks, CA

G

Gaetano M. De Ferrari

Cardiology Division, Department of Medical Sciences, University of Turin and Azienda Ospedaliero–Universitaria Città della Salute e della Scienza, Turin, Italy

L

Lawrence A. Leiter

Division of Endocrinology and Metabolism, St. Michael’s Hospital, University of Toronto, Toronto

J

Jose C. Nicolau

Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo

J

Jeong-Gun Park

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

J

Julia F. Kuder

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

S

Sabina A. Murphy

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

E

Emileigh Walsh

Amgen, Thousand Oaks, CA

H

Huei Wang

Amgen, Thousand Oaks, CA

V

Vladimír Blaha

A

Andrzej Budaj

Department of Cardiology, Center of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland

J

Jan H. Cornel

Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Radboudumc, Nijmegen, the Netherlands

A

Assen Goudev

Division of Cardiology, University Hospital Tsaritsa Yoanna, Sofia, Bulgaria

R

Robert Gabor Kiss

Department of Cardiology, Central Hospital of Northern Pest-Military Hospital, Budapest, Hungary

A

Alberto J. Lorenzatti

DAMIC (Docencia Asistencia Médica e Investigación Clínica) Medical Institute and Rusculleda Foundation for Research, Cordoba, Argentina

A

Alexander Parkhomenko

National Scientific Center “M.D. Strazhesko Institute of Cardiology,” Kyiv, Ukraine

M

Marcoli Cyrille

Amgen, Thousand Oaks, CA

G

Gabriel Paiva da Silva Lima

Amgen, Thousand Oaks, CA

E

E. Magnus Ohman

Amgen, Thousand Oaks, CA

R

Robert P. Giugliano

M

Marc S. Sabatine

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston